A foreign press reported that the prevention rate of the COVID-19 vaccine being developed by US pharmaceutical company Pfizer was 95% as a final result.
The AFP news agency said Pfizer said the vaccine had no serious side effects and would therefore apply for emergency use approval from US authorities within days.
Pfizer's Chief Executive Officer Albert Bola said, "This study is an important step in a historic eight-month journey to speed up the vaccine to end this pandemic," he said. "With hundreds of thousands of people infected around the world every day. "We urgently need to bring safe and efficient vaccines to the world."
This announcement came in a situation where the Corona 19 infection is again rapidly increasing in the United States and around the world.
On the 9th, Pfizer announced an interim result that the vaccine being developed with Bioentech in Germany has a prevention rate of more than 90%.
On the 16th, it was found that the prevention rate of COVID-19 vaccine candidates being developed by another pharmaceutical company Modena was 94.5%.
Following Modena, Pfizer's vaccine protection rate has also been announced to reach 95%, raising expectations that a wide range of vaccines will be available.